Maria Sainz - 08 Jan 2026 Form 4 Insider Report for PULSE BIOSCIENCES, INC. (PLSE)

Role
Director
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
08 Jan 2026
Net transactions value
$0
Form type
4
Filing time
06 Feb 2026, 21:21:10 UTC
Previous filing
31 May 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sainz Maria Director C/O PULSE BIOSCIENCES, INC., 3957 POINT EDEN WAY, HAYWARD /s/ Kenneth B. Stratton, as Attorney-in-Fact 06 Feb 2026 0001437768

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLSE Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 08 Jan 2026 Common Stock 50,000 $14.72 Direct F1
transaction PLSE Stock Option (right to buy) Award $0 +3,104 $0.000000 3,104 05 Feb 2026 Common Stock 3,104 $13.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares subject to the option will vest on the one-year anniversary of the grant and the remaining shares will vest on a monthly basis over two years thereafter, subject to the Reporting Person's continued service through each vesting date.
F2 The shares subject to the option will vest in equal installments on March 5, 2026 and June 5, 2026, subject to the Reporting Person's continued service through each vesting date.